E-Cadherin as a diagnostic biomarker in breast cancer

North American Journal of Medical Sciences

Volumn 3, Issue 5, 2011, Pages 227-233

  Singhai, Rajeev ^a   Patil, Vinayak W ^a   Jaiswal, Sanjog R ^c   Patil, Shital D ^a   Tayade, Mukund B ^a   Patil, Amit V ^b  

^a SIR J J GROUP OF HOSPITALS   (India)

^b Government Medical College   (India)

^c KEM HOSPITAL   (India)

Author keywords

Breast cancer; E Cadherin; Invasive carcinoma; Invasive ductal carcinoma; Invasive lobular carcinomas; Prognostic cancer tissue biomarkers; Tubulolobular carcinoma

Indexed keywords

TUMOR MARKER; UVOMORULIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST INVASIVE LOBULAR CARCINOMA; BREAST TUBULOBULAR CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; PREDICTIVE VALUE; PROGNOSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TUMOR CELL;

EID: 79955648340     PISSN: None     EISSN: 19472714     Source Type: Journal    
DOI: 10.4297/najms.2011.3227     Document Type: Article

References (39)

1. Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem 1990; 59: 237-252.
2. Berx G, Staes K, Van Hengel J, et al. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 1995; 26: 281-289.
3. Bracke ME, Van Roy FM, Mareel MM. The E-cadherin/catenin complex in invasion and metastasis. Curr Top Microbiol Immunol 1996; 213 (Pt 1): 123-161.
4. Larue L, Ohsugi M, Hirchenhain J, Kemler R. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc Natl Acad Sci USA 1994; 91: 8263-8267.
5. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-185.
6. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993; 5: 806-811.
7. Tang A, Amagai M, Granger LG, Stanley JR, Udey MC. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 1993; 361: 82-85.
8. Handschuh G, Candidus S, Luber B, et al. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene 1999; 18: 4301-4312.
9. Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995; 14: 6107-6115.
10. Vos CB, Cleton-Jansen AM, Berx G, et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997; 76: 1131-1133.
11. Kanai Y, Oda T, Tsuda H, Ochiai A, Hirohashi S. Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res 1994; 85: 1035-1039.
12. Vleminckx K, Vakaet L, Jr., Mareel M, Fiers W, Van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66: 107-119.
13. Pinder SE, Elston CW, Ellis IO, eds. Invasive carcinoma: usual histological types. 3rd ed. The Breast, ed. Elston CW, Ellis IO. 1998, Churchill Livingstone: Edinburgh, Scotland. 283-337.
14. Page DL, Anderson TJ, eds. Infiltrating carcinoma: major histological types. Diagnostic Histopathology of the Breast, ed. Page DL, Anderson TJ. 1987, Saunders: London, England. 193-235.
15. Eusebi V, Magalhaes F, Azzopardi JG. Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. Hum Pathol 1992; 23: 655-662.
16. Weidner N, Semple JP. Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol 1992; 23: 1167-1171.
17. Wahed A, Connelly J, Reese T. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma. Ann Diagn Pathol 2002; 6: 349-351.
18. Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 1992; 20: 479-489.
19. Acs G, Lawton TJ, Rebbeck TR, Livolsi VA, Zhang PJ. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001; 115: 85-98.
20. De Leeuw WJ, Berx G, Vos CB, et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997; 183: 404-411.
21. Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993; 142: 987-993.
22. Moll R, Mitze M, Frixen UH, Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993; 143: 1731-1742.
23. Goldstein NS. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases? Am J Clin Pathol 2002; 118: 425-434.
24. Charpin C, Garcia S, Bonnier P, et al. Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival. Am J Clin Pathol 1998; 109: 431-438.
25. Guriec N, Marcellin L, Gairard B, et al. E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival. Invasion Metastasis 1996; 16: 19-26.
26. Heimann R, Lan F, Mcbride R, Hellman S. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res 2000; 60: 298-304.
27. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 1996; 105: 394-402.
28. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993; 53: 1696-1701.
29. Hunt NC, Douglas-Jones AG, Jasani B, Morgan JM, Pignatelli M. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch 1997; 430: 285-289.
30. Lipponen P, Saarelainen E, Ji H, Aaltomaa S, Syrjanen K. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol 1994; 174: 101-109.
31. Elston CW, Ellis IO, eds. Assessment of histological grade. 3rd ed. The Breast, ed. Elston CW, Ellis IO. 1998, Churchill Livingstone: Edinburgh, Scotland. 365-384.
32. Gotte M, Kersting C, Radke I, Kiesel L, Wulfing P. An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ. Breast Cancer Res 2007; 9: R8.
33. Foote FW, Stewart FW. Lobular carcinoma in situ: A rare form of mammary cancer. Am J Pathol 1941; 17: 491-496.
34. Foote FW, Jr., Stewart FW. A histologic classification of carcinoma of the breast. Surgery 1946; 19: 74-99.
35. Wheeler JE, Enterline HT. Lobular carcinoma of the breast in situ and infiltrating. Pathol Annu 1976; 11: 161-88.
36. Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW. Infiltrating lobular carcinoma of the breast. Histopathology 1982; 6: 149-161.
37. Martinez V, Azzopardi JG. Invasive lobular carcinoma of the breast: incidence and variants. Histopathology 1979; 3: 467-488.
38. Fechner RE. Histologic variants of infiltrating lobular carcinoma of the breast. Hum Pathol 1975; 6: 373-378.
39. Fisher ER, Gregorio RM, Redmond C, Fisher B. Tubulolobular invasive breast cancer: a variant of lobular invasive cancer. Hum Pathol 1977; 8: 679-683.